|
1
|
Sweet D, Carnielli V, Greisen G, Hallman
M, Ozek E, Plavka R, Saugstad OD, Simeoni U, Speer CP and Halliday
HL; European Association of Perinatal Medicine, : European
consensus guidelines on the management of neonatal respiratory
distress syndrome in preterm infants--2013 update. Zhonghua Er Ke
Za Zhi. 52:749–755. 2014.(In Chinese). PubMed/NCBI
|
|
2
|
Zhou B, Zhai JF, Wu JB, Jin B and Zhang
YY: Different ventilation modes combined with ambroxol in the
treatment of respiratory distress syndrome in premature infants.
Exp Ther Med. 13:629–633. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rodriguez RJ: Management of respiratory
distress syndrome: An update. Respir Care. 48:279–286; discussion
286–287. 2003.PubMed/NCBI
|
|
4
|
Liszewski MC, Stanescu AL, Phillips GS and
Lee EY: Respiratory distress in neonates: Underlying causes and
current imaging assessment. Radiol Clin North Am. 55:629–644. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tochie JN, Choukem SP, Langmia RN, Barla E
and Koki-Ndombo P: Neonatal respiratory distress in a reference
neonatal unit in Cameroon: An analysis of prevalence, predictors,
etiologies and outcomes. Pan Afr Med J. 24:1522016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tabit CE, Chung WB, Hamburg NM and Vita
JA: Endothelial dysfunction in diabetes mellitus: Molecular
mechanisms and clinical implications. Rev Endocr Metab Disord.
11:61–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jobe AH: Lung maturational agents and
surfactant treatments: Are they complementary in preterm infants? J
Perinatol. 9:14–18. 1989.PubMed/NCBI
|
|
8
|
Speer CP: Neonatal respiratory distress
syndrome: An inflammatory disease? Neonatology. 99:316–319. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rijal P and Shrestha M: Scenario of
neonatal respiratory distress in tertiary hospital. J Nepal Health
Res Counc. 16:131–135. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gitaka J, Natecho A, Mwambeo HM, Gatungu
DM, Githanga D and Abuya T: Evaluating quality neonatal care, call
centre service, tele-health and community engagement in reducing
newborn morbidity and mortality in Bungoma county, Kenya. BMC
Health Serv Res. 18:4932018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan YZ and Wen ZL: Efficacy of different
dosages of ambroxol hydrochloride in the prevention of neonatal
respiratory distress syndrome. Zhongguo Dang Dai Er Ke Za Zhi.
11:771–772. 2009.(In Chinese). PubMed/NCBI
|
|
12
|
Wu X, Li S, Zhang J, Zhang Y, Han L, Deng
Q and Wan X: Meta-analysis of high doses of ambroxol treatment for
acute lung injury/acute respiratory distress syndrome based on
randomized controlled trials. J Clin Pharmacol. 54:1199–1206. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ketko AK and Donn SM:
Surfactant-associated proteins: Structure, function and clinical
implications. Curr Pediatr Rev. 10:162–167. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gortner L, Schüller SS and Herting E:
Review demonstrates that less invasive surfactant administration in
preterm neonates leads to fewer complications. Acta Paediatr.
107:736–743. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang C and Zhu X: Clinical effects of
pulmonary surfactant in combination with nasal continuous positive
airway pressure therapy on neonatal respiratory distress syndrome.
Pak J Med Sci. 33:621–625. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Baranwal AK, Murthy AS and Singhi SC:
High-dose oral ambroxol for early treatment of pulmonary acute
respiratory distress syndrome: An exploratory, randomized,
controlled pilot trial. J Trop Pediatr. 61:339–350. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gonzalez Garay AG, Reveiz L, Velasco
Hidalgo L and Solis Galicia C: Ambroxol for women at risk of
preterm birth for preventing neonatal respiratory distress
syndrome. Cochrane Database Syst Rev (10). CD0097082014.
|
|
18
|
Zhang ZQ, Huang XM and Lu H: Ambroxol for
the prevention of respiratory distress syndrome in preterm infants:
A meta analysis. Zhongguo Dang Dai Er Ke Za Zhi. 12:858–863.
2010.(In Chinese). PubMed/NCBI
|
|
19
|
Elsayed HF, Elkhaiouby MI, Elsharkawey SM
and Elnemr MA: Evaluation of the role of postnatal ambroxol in the
prevention and treatment of respiratory distress syndrome in
preterm neonates. Sultan Qaboos Univ Med J. 6:41–46.
2006.PubMed/NCBI
|
|
20
|
Carrera G, Liberatore A, Riboni G and
Clementi M: Surfactant and ambroxol in the therapy of idiopathic
respiratory syndrome in newborn infants. Minerva Pediatr.
43:723–730. 1991.(In Italian). PubMed/NCBI
|
|
21
|
Marini A, Franzetti M, Gios G, Flauto U,
Arosio A, Maccabruni M, Rondini G, Chirico G, Giancola A, Console
V, et al: Ambroxol in the treatment of idiopathic respiratory
distress syndrome. An interim report on a controlled double-blind
multicenter study versus placebo. Respiration. 51 (Suppl 1):60–67.
1987. View Article : Google Scholar : PubMed/NCBI
|
